Open AccessPPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways
Author(s) -
Jordi Camps,
Anabel GarcíaHeredia,
Anna Rull,
Carlos AlonsoVillaverde,
Gerard Aragonès,
Raúl BeltránDebón,
Esther RodríguezGallego,
Jorge Joven
Publication year - 2012
Publication title -
ppar research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 49
eISSN - 1687-4765
pISSN - 1687-4757
DOI - 10.1155/2012/616371
Subject(s) - pon1 , paraoxonase , oxidative stress , inflammation , downregulation and upregulation , peroxisome proliferator activated receptor , pharmacology , microbiology and biotechnology , biology , chemistry , biochemistry , receptor , immunology , gene , genotype
The paraoxonase (PON) group of enzymes, composed of PON1, PON2, and PON3, play an important role in decreasing oxidative stress by degrading lipid peroxides. PON1 synthesis is upregulated by PPAR. Several pharmacological compounds (acting as antioxidants and, hence, atheroprotective) stimulate both PPAR activity and PON1 expression. Recent evidence suggests that PON1 and the monocyte chemoattractant protein-1 (MCP-1) are involved in coordinating the inflammatory response in damaged tissues; PPAR may be central in the regulation of these biochemical pathways. This article reviews the state of knowledge on PON1 biochemistry and function, the influence of genetic variation, and the regulation of PON1 expression by pharmaceutical compounds that increase PPAR activity. We also describe recent lines of evidence suggesting links between PON1 and MCP-1 and how their production may be regulated by PPAR.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom